Pharsight

Levoxyl patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6555581 KING PHARMS Levothyroxine compositions and methods
Feb, 2022

(2 years ago)

US7067148 KING PHARMS Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
Feb, 2022

(2 years ago)

US7101569 KING PHARMS Methods of administering levothyroxine pharmaceutical compositions
Oct, 2023

(8 months ago)

Levoxyl is owned by King Pharms.

Levoxyl contains Levothyroxine Sodium.

Levoxyl has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Levoxyl are:

  • US6555581
  • US7067148
  • US7101569

Levoxyl was authorised for market use on 25 May, 2001.

Levoxyl is available in tablet;oral dosage forms.

Levoxyl can be used as method of use of administering levothyroxine.

The generics of Levoxyl are possible to be released after 02 October, 2023.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 25 May, 2001

Treatment: Method of use of administering levothyroxine

Dosage: TABLET;ORAL

How can I launch a generic of LEVOXYL before it's drug patent expiration?
More Information on Dosage

LEVOXYL family patents

Family Patents